Hamman-Rich syndrome pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The exact pathogenesis of [disease name] is not fully understood.
OR
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Pathophysiology
Pathogenesis
- The exact pathogenesis of [disease name] is not fully understood.
OR
- It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
- [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
- The progression to [disease name] usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
Genetics
- [Disease name] is transmitted in [mode of genetic transmission] pattern.
- Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
- The development of [disease name] is the result of multiple genetic mutations.
Associated Conditions
Gross Pathology
- Patients with acute interstitial pneumonitis, gross appearance of lungs is identical to the patients with ARDS.
- The gross appearance of lungs correlates with the stage of the diffuse alveolar damage.
- In the early phase, the lungs are firm, boggy, and have a dark red or beefy appearance.
- In later phases, the lungs are extremely heavy due to edema and show irregular areas of dense consolidation and fibrosis.
- As the fibrosis progresses, cobblestoning of the pleural surface may occur.
- Formation of peripheral cysts and honeycombing may suggest the possibility of underlying chronic fibrotic lung disease.
Microscopic Pathology
- On microscopic histopathological analysis, Acute interstitial pneumonitis will show following features:[1][2]
- Diffuse alveolar damage
- Hyaline membrane formation
- Interstitial fibrosis:
- It is diffuse, uniform temporally with extensive fibroblastic and myofibroblastic proliferation and relatively less collagen deposition.
- The uniformity of the fibroblastic/myofibroblastic proliferation and prominent activity distinguish AIP from the other types of idiopathic interstitial pneumonia.
- Type II pneumocyte hyperplasia with cytologic atypia and bronchiolar squamous metaplasia is present.
- Thickening and distortion of alveolar septa caused by spindle cell proliferation.
- Intraluminal polypoid plugs formation
- Organizing thrombi in small and medium-sized arteries
- Biopsies taken in the later course of the disease show:
- Enlarged and remodeled airspaces that resemble honeycomb change of UIP (usual interstitial fibrosis), but extensive fibroblastic/ myofibroblastic proliferation and collagen deposition is still present within the walls of the alveoli.
References
- ↑ Mukhopadhyay S, Parambil JG (October 2012). "Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS)". Semin Respir Crit Care Med. 33 (5): 476–85. doi:10.1055/s-0032-1325158. PMID 23001802.
- ↑ Bonaccorsi A, Cancellieri A, Chilosi M, Trisolini R, Boaron M, Crimi N, Poletti V (January 2003). "Acute interstitial pneumonia: report of a series". Eur. Respir. J. 21 (1): 187–91. PMID 12570127.